Bengaluru-based neurotechnology startup Mave Health has raised $2.1 million (Rs 18 crore) in a seed funding round led by Blume Ventures. The round also saw participation from Inuka Capital, Stanford Angels, Founders of Groww, Raymond Russell, Aureolis Ventures and Juhi Bhatnagar (Forj Capital), with existing investors, including All In Capital, doubling down on their investment. The funding follows the company’s $750,000 pre-seed round raised in November 2023.
Founded in 2023 by Dhawal Jain, Jai Sharma, and Aman Kumar, Mave Health is building a wearable headset that supports everyday mental health and cognitive performance in just 20 minutes a day. Its underlying technology, transcranial direct current stimulation (tDCS), has been studied for over 25 years, with more than 10,000 published papers globally.
Mave debuted with over 500 beta customers ahead of its public release last month. Based on self-reported data collected after four weeks of use, 80% reported productivity gains exceeding 60%, 75% reported stress reductions above 50% and users reported an average mood improvement of 77%.
The newly raised capital will be used to launch Mave’s wearable headset in the United States and India, and to expand manufacturing capabilities.
The startup recently released three limited batches that sold out within 36 hours, and its launch video has generated over a million impressions across social platforms. The product has also drawn attention from multiple global technology leaders and athletes including UFC Fighter Max Griffin.
Mave’s device is currently available for pre-order in the US and India. Shipping begins in April 2026.
